Clinical Management of Circulating Tumor DNA in Breast Cancer: Detection, Prediction, and Monitoring
{{output}}
Despite substantial progress in the diagnosis and treatment of breast cancer, current therapeutic regimens exhibit limitations, necessitating the identification of more robust biomarkers to optimize personalized strategies. Circulating tumor DNA (ctDNA), as a ... ...
